A Study of JR-141 in Patients With Mucopolysaccharidosis II
Clinical trial NCT03568175 · COMPLETED
Trial details
- NCT number
- NCT03568175
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-02-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.